Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

63.62
-1.3600-2.09%
Post-market: 63.620.00000.00%19:30 EST
Volume:1.09M
Turnover:69.47M
Market Cap:6.93B
PE:47.87
High:65.13
Open:64.07
Low:62.81
Close:64.98
52wk High:126.38
52wk Low:28.66
Shares:109.00M
Float Shares:97.89M
Volume Ratio:1.12
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.33
EPS(LYR):0.8200
ROE:22.15%
ROA:7.46%
PB:8.32
PE(LYR):77.59

Loading ...

Corcept Therapeutics Director James N. Wilson Reports Disposal of $726,677.9383 in Common Shares

Reuters
·
Nov 18

Movement Alert|Corcept Therapeutics Falls 4.25% in Regular Trading, Q3 Beat Overshadowed by Unchanged Full-Year Outlook

Market Focus
·
Nov 17

Corcept Reports Eight-Year Response to Relacorilant Combination in Vulvar Cancer Patient

Reuters
·
Nov 16

Corcept Therapeutics Director Daniel N. Swisher Jr. Sells $111,105 in Common Shares

Reuters
·
Nov 14

Corcept Therapeutics (CORT) Shares Dropped, So What Is Driving Attention Now?

Simply Wall St.
·
Nov 11

Lifyorli Sales Surge Could Reshape Corcept Therapeutics Stock Story

Simply Wall St.
·
Nov 06

Puma Biotechnology Q3 Product Revenue Rises on Increased Nerlynx Demand

Reuters
·
Nov 06

Corcept Therapeutics (CORT) Stock Trades At A Premium On Strong Q3 Earnings

Simply Wall St.
·
Nov 05

AI-Driven Cyber and Data Security Risks Threaten Corcept Therapeutics’ Operations and Financial Performance

TIPRANKS
·
Nov 05

Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira Reports Sale of Common Shares Worth $674,068.7958

Reuters
·
Nov 05

Corcept Therapeutics Price Target Raised to $173.00/Share from $165.00 by Piper Sandler

Dow Jones
·
Nov 05

US Research Roundup-Amgen, Carmax, Pfizer

Reuters
·
Nov 04

Corcept Therapeutics Incorporated Reports Results for the Quarter Ended September 30 - Earnings Summary

Reuters
·
Nov 04

Corcept Therapeutics Forecasts 2026 Revenue of $1.1 Billion-$1.2 Billion

Reuters
·
Nov 04

GUIDANCE: (CORT) Corcept Therapeutics Reiterates 2026 Revenue Guidance of $1.1B-$1.2B, vs. FactSet Est of $1.15B

MT Newswires Live
·
Nov 04

Earnings Flash (CORT) Corcept Therapeutics Posts Q3 EPS $1.01, vs. FactSet Est of $0.79

MT Newswires Live
·
Nov 04

Corcept Therapeutics Q3 Revenue Beats Estimates on Strong Lifyorli Uptake

Reuters
·
Nov 04

Corcept Therapeutics Q3 EPS USD 1.01

Reuters
·
Nov 04

Analysts Are Bullish on Top NA Stocks: Seaport Therapeutics, Inc. (SPTX), Corcept Therapeutics (CORT)

TIPRANKS
·
Nov 03

Corcept Therapeutics Updates Financial Calendar

Reuters
·
Oct 28